Quinoxaline 1,4-di-N-oxide and the Potential for Treating Tuberculosis

Quinoxaline 1,4-di-N-oxide and the Potential for Treating Tuberculosis

New drugs active against drug-resistant tuberculosis are urgently needed to extend the range of TB treatment options to cover drug resistant infections. Quinoxaline derivatives show very interesting biological properties (antibacterial, antiviral, anticancer, antifungal, antihelmintic, insecticidal)...

ver descrição completa

Detalhes bibliográficos
Principais autores: Vicente, E. (Esther), Raquel, Pérez-Silanes, S. (Silvia), Aldana, I. (Ignacio), Goldman, R.C. (Robert C.), Monge, A. (Antonio), Solano, B. (Beatriz), Burguete, A. (Asunción), Ancizu, S. (Saioa), Zarranz, B. (Belén), Jaso, A. (Andrés), Marin, A. (Adoración)
Formato: info:eu-repo/semantics/article
Idioma:eng
Publicado em: Bentham Science Publishers 2011
Assuntos:
Tuberculosis
Quinoxaline 1,4-di-N-oxide
Mycobacterium
Acesso em linha:https://hdl.handle.net/10171/18728

Internet

https://hdl.handle.net/10171/18728

Registros relacionados